Literature DB >> 27158932

Membrane-targeting AM-0016 kills mycobacterial persisters and shows low propensity for resistance development.

Devika Mukherjee1, Hanxun Zou2, Shouping Liu2,3, Roger Beuerman2,3,4, Thomas Dick1.   

Abstract

AIM: To test the hypothesis that targeting the cytoplasmic membrane may be an effective way to kill persister mycobacteria and delay the emergence of resistance.
METHODS: In vitro activity of AM-0016, a novel xanthone-based antibacterial, was assessed against growing and persister tubercle bacilli. Resistance mutation frequencies were determined. Biochemical membrane and electron microscopic analyses were carried out.
RESULTS: AM-0016 rapidly sterilized growing tubercle bacillus cultures and displayed strong bactericidal activity against persister bacteria. Spontaneous resistance mutation frequency was lower than 10(-8). Exposure to AM-0016 resulted in rapid collapse of the membrane potential. Imaging revealed deformation of the cell envelope.
CONCLUSION: Targeting the cytoplasmic membrane may be an attractive approach to eliminate persister mycobacteria and slow down the emergence of genetic drug resistance.

Entities:  

Keywords:  drug resistance; drug tolerance; tuberculosis

Mesh:

Substances:

Year:  2016        PMID: 27158932     DOI: 10.2217/fmb-2015-0015

Source DB:  PubMed          Journal:  Future Microbiol        ISSN: 1746-0913            Impact factor:   3.165


  13 in total

Review 1.  Targeting Phenotypically Tolerant Mycobacterium tuberculosis.

Authors:  Ben Gold; Carl Nathan
Journal:  Microbiol Spectr       Date:  2017-01

Review 2.  NTM drug discovery: status, gaps and the way forward.

Authors:  Mu-Lu Wu; Dinah B Aziz; Véronique Dartois; Thomas Dick
Journal:  Drug Discov Today       Date:  2018-04-07       Impact factor: 7.851

Review 3.  Persistent bacterial infections and persister cells.

Authors:  Robert A Fisher; Bridget Gollan; Sophie Helaine
Journal:  Nat Rev Microbiol       Date:  2017-05-22       Impact factor: 60.633

4.  Whole-Cell Screen of Fragment Library Identifies Gut Microbiota Metabolite Indole Propionic Acid as Antitubercular.

Authors:  Dereje A Negatu; Joe J J Liu; Matthew Zimmerman; Firat Kaya; Véronique Dartois; Courtney C Aldrich; Martin Gengenbacher; Thomas Dick
Journal:  Antimicrob Agents Chemother       Date:  2018-02-23       Impact factor: 5.191

5.  Extraction and quantification of biofilm bacteria: Method optimized for urinary catheters.

Authors:  Kedar Diwakar Mandakhalikar; Juwita Norasmara Rahmat; Edmund Chiong; Koon Gee Neoh; Liang Shen; Paul Anantharajah Tambyah
Journal:  Sci Rep       Date:  2018-05-23       Impact factor: 4.379

6.  Phenanthrene Antibiotic Targets Bacterial Membranes and Kills Staphylococcus aureus With a Low Propensity for Resistance Development.

Authors:  Bo-Chen Chen; Chang-Xin Lin; Ni-Pi Chen; Cheng-Xian Gao; Ying-Jie Zhao; Chao-Dong Qian
Journal:  Front Microbiol       Date:  2018-07-17       Impact factor: 5.640

7.  Antibiotic in myrrh from Commiphora molmol preferentially kills nongrowing bacteria.

Authors:  Mrinal K Bhattacharjee; Tahrir Alenezi
Journal:  Future Sci OA       Date:  2020-02-20

Review 8.  Challenging the Drug-Likeness Dogma for New Drug Discovery in Tuberculosis.

Authors:  Diana Machado; Miriam Girardini; Miguel Viveiros; Marco Pieroni
Journal:  Front Microbiol       Date:  2018-07-03       Impact factor: 5.640

Review 9.  The Mycobacterial Membrane: A Novel Target Space for Anti-tubercular Drugs.

Authors:  Huan Chen; Samuel A Nyantakyi; Ming Li; Pooja Gopal; Dinah B Aziz; Tianming Yang; Wilfried Moreira; Martin Gengenbacher; Thomas Dick; Mei L Go
Journal:  Front Microbiol       Date:  2018-07-19       Impact factor: 5.640

10.  Restriction of in vivo infection by antifouling coating on urinary catheter with controllable and sustained silver release: a proof of concept study.

Authors:  Kedar Diwakar Mandakhalikar; Rong Wang; Juwita N Rahmat; Edmund Chiong; Koon Gee Neoh; Paul A Tambyah
Journal:  BMC Infect Dis       Date:  2018-08-06       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.